Therapy News and Research

RSS

NIDDK director to receive Outstanding Achievement Award from NKF

The National Kidney Foundation will honor Dr. Griffin P. Rodgers, Director of the National Institute of Diabetes and Digestive and Kidney Diseases, one of the National Institutes of Health, for his commitment to bettering the lives of patients and raising awareness of chronic kidney disease.

7 Nov 2013

Linagliptin shows efficacy, tolerability in adults with T2D and liver disease

Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.

7 Nov 2013

Researchers, clinicians discuss recent findings that could bring hope for people with HIV

Since the onset of the AIDS pandemic more than three decades ago, researchers from the lab and physicians in the clinic have been working toward one shared goal: an AIDS-free world. This week, a conference hosted by the journals Cell and The Lancet brought leading researchers and clinicians together to discuss recent findings that could bring hope to the estimated 35 million people world-wide who live with HIV.

7 Nov 2013

University of Adelaide research uses special adult stem cells to treat Hurler's syndrome

University of Adelaide research using special adult stem cells is promising new hope for better treatments for the devastating genetic disease Hurler's syndrome.

7 Nov 2013

New study uses genomic sequencing to develop treatments for castration-resistant prostate cancer

A new study at Mayo Clinic is using genomic sequencing to develop customized treatments for men with castration-resistant prostate cancer, a progressive and incurable stage of prostate cancer, which no longer responds to hormone therapies that stop or slow testosterone production.

7 Nov 2013

Alliance HealthCare Services third quarter 2013 revenue decreases $2.6 million

Alliance HealthCare Services, Inc., a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced results for the third quarter ended September 30, 2013.

6 Nov 2013

Brookdale Senior Living's total revenue increases $32.9 million in third quarter 2013

Brookdale Senior Living Inc. today reported financial and operating results for the third quarter of 2013.

6 Nov 2013

Advanced prostate cancer therapies: an interview with Dr. Nancy Dawson, Lombardi Comprehensive Cancer Center

The prostate gland produces part of the seminal fluid that protects sperm. It is located in front of the rectum and under the bladder, and surrounds the urethra, the tube through which urine flows from the bladder to and out of the penis.

6 Nov 2013

Sleep Science's new OSA treatment to be presented in WHO Compendium of Innovative Technologies

Sleep Science Partners' mandibular repositioning treatment for obstructive sleep apnea has been accepted for inclusion in the 2013 World Health Organization Compendium of Innovative Technologies to be published this November.

6 Nov 2013

Use of testosterone therapy after angiography associated with increased risk of death

Among a group of men who underwent coronary angiography and had a low serum testosterone level, the use of testosterone therapy was associated with increased risk of death, heart attack, or ischemic stroke, according to a study in the November 6 issue of JAMA.

6 Nov 2013

New drug combination therapy effectively kills cancer cells

Results from a recent preclinical study have shown that a new drug combination therapy being developed at Virginia Commonwealth University Massey Cancer Center effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.

6 Nov 2013

New treatment option for patients with most difficult-to-treat forms of hepatitis C

A novel single-pill combination drug could present a new treatment option for patients with the most difficult-to-treat forms of hepatitis C, according to the results of a Phase 2 trial, published in The Lancet.

6 Nov 2013

Endocrine Society publishes Clinical Practice Guideline on diabetes and pregnancy

The Endocrine Society today issued a Clinical Practice Guideline to help health care professionals provide the best care to pregnant women who have diabetes.

6 Nov 2013

Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlanta, GA

The go-to source for excellence in continuing medical education, Physicians' Education Resource®, LLC, will host the 11th Annual School of Breast Oncology November 7-10 at the Emory University Conference Center in Atlanta, GA.

6 Nov 2013

Tel Aviv University researchers study long-term effects of torture on human pain system

Israeli soldiers captured during the 1973 Yom Kippur War were subjected to brutal torture in Egypt and Syria. Held alone in tiny, filthy spaces for weeks or months, sometimes handcuffed and blindfolded, they suffered severe beatings, burns, electric shocks, starvation, and worse.

6 Nov 2013

Scientists investigate combined action of two different compounds against CML

Currently no treatment option is available for five percent of patients suffering from chronic myelogenous leukemia, since they have developed resistance to conventional medications. Prof. Stephan Grzesiek's group at the Biozentrum of the University of Basel, in collaboration with Dr. Wolfgang Jahnke and colleagues from Novartis, has investigated the combined action of two different compounds against this form of leukemia.

6 Nov 2013

FDA grants Orphan Drug Designation to Advaxis' ADXS-HPV for HPV-associated head and neck cancer

Advaxis, Inc.,, a leader in developing the next generation of cancer immunotherapies, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated head and neck cancer.

6 Nov 2013

One Lambda gets CE mark approval in Europe for C1qScreen assay

One Lambda Inc., part of Thermo Fisher Scientific and a leading producer of in vitro diagnostic products for the human leukocyte antigen transplant community, has received CE mark approval in Europe for its C1qScreen assay.

6 Nov 2013

Depomed reports financial results for third quarter 2013

Total revenues were $37.5 million and included recognition of a $5.0 million milestone payment from Mallinckrodt related to the NDA filing of MNK-795. Excluding this milestone and a $10 million upfront payment from Janssen in the third quarter of 2012, total revenues of $32.5 million grew 39% compared to $23.3 million for the third quarter of 2012.

6 Nov 2013

Duke Cancer Institute is one among 41 cancer centers in U.S to hold distinction

Established and designated by the National Cancer Institute as one of eight original comprehensive cancer centers in 1973, the Duke Cancer Institute (DCI) is now among just 41 cancer centers in the United States to hold that distinction.

6 Nov 2013

Therapy News and Research

NIDDK director to receive Outstanding Achievement Award from NKF

Linagliptin shows efficacy, tolerability in adults with T2D and liver disease

Researchers, clinicians discuss recent findings that could bring hope for people with HIV

University of Adelaide research uses special adult stem cells to treat Hurler's syndrome

New study uses genomic sequencing to develop treatments for castration-resistant prostate cancer

Alliance HealthCare Services third quarter 2013 revenue decreases $2.6 million

Brookdale Senior Living's total revenue increases $32.9 million in third quarter 2013

Advanced prostate cancer therapies: an interview with Dr. Nancy Dawson, Lombardi Comprehensive Cancer Center

Sleep Science's new OSA treatment to be presented in WHO Compendium of Innovative Technologies

Use of testosterone therapy after angiography associated with increased risk of death

New drug combination therapy effectively kills cancer cells

New treatment option for patients with most difficult-to-treat forms of hepatitis C

Endocrine Society publishes Clinical Practice Guideline on diabetes and pregnancy

Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlanta, GA

Tel Aviv University researchers study long-term effects of torture on human pain system

Scientists investigate combined action of two different compounds against CML

FDA grants Orphan Drug Designation to Advaxis' ADXS-HPV for HPV-associated head and neck cancer

One Lambda gets CE mark approval in Europe for C1qScreen assay

Depomed reports financial results for third quarter 2013

Duke Cancer Institute is one among 41 cancer centers in U.S to hold distinction

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News